Skip to main content
OpenTrials

Clinical trial condition

Atrophic Vaginitis

Explore clinical trials studying Atrophic Vaginitis. Study availability and eligibility vary by location and protocol.

34 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Atrophic Vaginitis trial results

Completed

Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy

NCT02691936

Conditions
Atrophic Vaginitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • Stanford University Stanford, California, United States
  • Washington Hospital Center Washington D.C., District of Columbia, United States
  • Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
  • Christ Hospital Cincinnati, Ohio, United States
View Trial Details
Completed

DHEA Against Vaginal Atrophy - Safety Study of 12 Months

NCT01256671

Conditions
Atrophic Vaginitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • EndoCeutics site # 39 Montgomery, Alabama, United States
  • EndoCeutics site # 14 Tucson, Arizona, United States
  • EndoCeutics site # 21 Sacramento, California, United States
  • EndoCeutics site # 30 San Diego, California, United States
View all 41 locations
View Trial Details
Completed

Topical DHEA Against Vaginal Atrophy

NCT01846442

Conditions
Atrophic Vaginitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • EndoCeutics site # 05 Cleveland, Ohio, United States
  • EndoCeutics site # 03 Norfolk, Virginia, United States
  • EndoCeutics site # 10 Montreal, Quebec, Canada
  • EndoCeutics site # 09 Montreal, Quebec, Canada
View Trial Details
Completed

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study

NCT01256684

Conditions
Atrophic Vaginitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • EndoCeutics site # 39 Montgomery, Alabama, United States
  • EndoCeutics site # 14 Tucson, Arizona, United States
  • EndoCeutics site # 21 Sacramento, California, United States
  • EndoCeutics site # 30 San Diego, California, United States
View all 33 locations
View Trial Details
Completed

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

NCT01358760

Conditions
Atrophic Vaginitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • EndoCeutics site # 39 Montgomery, Alabama, United States
  • EndoCeutics site # 14 Tucson, Arizona, United States
  • EndoCeutics site # 65 Little Rock, Arkansas, United States
  • EndoCeutics site # 21 Sacramento, California, United States
View all 42 locations
View Trial Details
Completed

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

NCT02013544

Conditions
Atrophic Vaginitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • EndoCeutics site # 39 Montgomery, Alabama, United States
  • EndoCeutics site # 14 Tucson, Arizona, United States
  • EndoCeutics site # 21 Sacramento, California, United States
  • EndoCeutics site # 83 San Diego, California, United States
View all 38 locations
View Trial Details

Related conditions